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Abstract
5-methylcytosine DNA methylation regulates gene expression and developmental program-
ming in a broad range of eukaryotes. However, its presence and potential roles in ciliates,
complex single-celled eukaryotes with germline-somatic genome specialization via nuclear
dimorphism, are largely uncharted. While canonical cytosine methyltransferases have not
been discovered in published ciliate genomes, recent studies performed in the stichotri-
chous ciliate Oxytricha trifallax suggest de novo cytosine methylation during macronuclear
development. In this study, we applied bisulfite genome sequencing, DNA mass spectrome-
try and antibody-based fluorescence detection to investigate the presence of DNA methyla-
tion in Paramecium tetraurelia. While the antibody-based methods suggest cytosine
methylation, DNA mass spectrometry and bisulfite sequencing reveal that levels are actually
below the limit of detection. Our results suggest that Paramecium does not utilize 5-methyl-
cytosine DNA methylation as an integral part of its epigenetic arsenal.
Introduction
The C5 position of cytosine can get methylated by DNA methyltransferases (DNMTs) into
methylcytosine (5mC) and is necessary for the maintenance of chromatin structure, gene
expression, and many chromatin-related processes[1–3]. 5mC has been extensively studied for
its role in biological processes such as genomic imprinting, X chromosome inactivation and
has long been implicated in human disease[3–8]. Furthermore, DNA methylation is also
essential for sexual dimorphism[9], DNA repair[10] and for the suppression of transposable
elements[11–13] in many organisms. DNA methylation is heritable and actively maintained
by methyltransferases. However, it can be removed by the suppression of maintenance methyl-
transferases or by the action of specific demethylases. Cytosine methylation occurs mostly at
the CpG or CNG sites in vertebrates and many other species across all phylogenetic kingdoms
[14–17]. Cytosine methylation in motifs other than CpG and CNF has been shown in plants
and Drosophila [18], [19]. Other eukaryotes such as S. pombe[20] and C. elegans[21] are devoid
of cytosine methylation in their genome.
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Paramecium tetraurelia is a unicellular eukaryote in the phylum ciliophoran exhibiting the
characteristic nuclear dimorphism. Paramecium cells, like any other ciliate can go through
either asexual or sexual way of reproduction. In Paramecium, one extensively studied phenom-
enon is its genome reorganization that occurs during the sexual life cycle[22]. During sexual
cycle, the somatic macronucleus is degraded and lost, and a new somatic nucleus formed. Dur-
ing the new macronuclear development, somatic macronucleus is formed from the zygote that
comes from cell’s germline-specific micronucleus. The formation of a functional somatic
genome requires massive genome reorganization and the removal of germline-specific
sequences[22] in macronuclear progenies of the zygotic nuclei.
The most remarkable example of such germline sequences is Internal Eliminated Sequences
(IESs) that typically interrupt protein coding regions. Instructions for proper IES excision and
ligation of gene segments is in part communicated from the maternal macronucleus during mac-
ronuclear development, though the specific mechanisms involved are still poorly understood[23].
Three alternative hypotheses attempt to explain the mechanism of IES targeting[24]
through pathways involving a novel class of small RNAs, called scnRNAs. scnRNAs are gener-
ated from transcription of the germline genome during meiosis. The first hypothesis suggests
scnRNAs direct histone modifications that mark IESs for elimination. Recent work suggests
that histone modifications are scnRNA dependent and are required for IES excision[25]. How-
ever, most of the IESs in Paramecium are smaller than the size of a nucleosome[26], and hence
this hypothesis seemingly cannot explain the precise targeting of smaller IESs. The second
hypothesis suggests deposition of specific DNA modifications that mark IESs for excision (or
gene segments for retention). The macronuclear genome does contain N6-methyladenosines,
but the presence of 5mC is still not clear[27]. The third hypothesis suggests that the scnRNAs
themselves directly help in the targeting of IESs for excision. The primary challenge to this
hypothesis is the presence of IESs whose precise excision is scnRNA independent.
Indirect evidence using cytosine analogs suggests that cytosine methylation might be present
in the genome[28], [29] even though homologs of canonical DNA methyltransferase are seem-
ingly absent. These studies argue that the somatic nucleus is programmed by 5-methyl cytosines
that leads to the repression of certain somatogenic sequences during sexual cycle. The argument is
based on the findings where administration of 5-azacytidine during sexual reproduction in Para-
mecium alter expression of certain somatogenic sequences in the subsequent asexual cycles. Fur-
thermore, recent study in another ciliate Oxytricha trifallax also showed evidence for the presence
of methylated cytosines in the genome using mass-spectrometry and bisulfite sequencing[30]. In
order to clarify this paradox and refine potential models for DNA elimination we measured the
levels and locations of DNA 5mC in Paramecium tetraurelia using multiple methods.
Materials and methods
Culture conditions for Paramecium tetraurelia
Paramecium tetraurelia strain 51 cells, mating type 7, were used for the experiments. Parame-
cium cells were grown in 1x wheat grass powder (WGP, Pines International) bacterized with a
non-virulent strain of Klebsiella pneumonia. β-Sitosterol, essential for Paramecium growth (0.8
mg/l), was added to WGP medium just before the feeding the cells[31]. For DNA mass spec-
trometry, cells were fed with DCM- E. coli (C29251, NEB) instead of Klebsiella pneumonia.
Cells were either cultured at 27˚C or 18˚C as per requirement.
Colorimetric quantification of methylated DNA
Total genomic DNA was extracted from different developmental stages after the treatment
with RNase A (R6148, Sigma) treatment using phenol: chloroform: IAA. The colorimetric
5-methylcytosine in Paramecium
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quantification of 5-methyl cytosines in total genomic DNA was done using EpiSeeker methyl-
ated DNA Quantification Kit (ab117128, Abcam). Briefly, DNA is bound to strip wells (pro-
vided with the kit) having a high DNA and the methylated DNA is captured and detected
using antibodies that are then quantified by reading the absorbance in a microplate spectro-
photometer. The amount of methylated DNA is proportional to the measured OD intensity.
Immunofluorescence
100 μl of cells from each time point were transferred to a 1.5 ml tube and washed twice with
1ml of 1x PBS after the incubation for 5 minutes each. The cells were then centrifuged at
350rcf for 2 min. After removing the supernatant, cells were treated with 1 ml Triton X-100 in
PHEM (5x PHEM: 50 mM EGTA, 125 mM HEPES, 10 mM MgCl2, 300 mM PIPES) and incu-
bated for 20 min for permeabilization. Cells were then treated with,2% PFA in PHEM for 15
min, followed by two PBS washes. After that, the cells were incubated in 1 ml of 0.1 M HCl for
5 min and then washed again with 1XPBS. Cells were then blocked for 20 min with 1 ml of 3%
BSA (3% BSA+ 0.1% Triton X-100 in TBSTEM (10 mM EGTA, 2 mM MgCl2, 0.15 M NaCl,
10 mM Tris, pH adjusted to 7.4. Tween 20 (1%, v/v)). For primary antibody anti-5-methylcyto-
sine (Abcam, ab73938) in the mouse was used in a 1:100 at room temperature. The cells were
washed twice in PBS for 10 min and then the secondary antibody, goat-anti-mouse Alexa
Fluor 488 (Invitrogen) was added to a final volume of 500 μl. Cell samples were incubated for
1.5 h at 37˚C. The cells were rewashed twice in PBS for 10 min and then DAPI (1 μg) stained
in 1 ml BSA Mix for 3 min. 20μl mounting medium (Prolong Gold Antifade, Invitrogen) was
added into the samples and the slides were sealed using cover slips.
Confocal microscopy
Confocal images were taken on an Olympus Fluoview FV1000 confocal microscope. For the
detection of 5mC, images were taken with UPLSAPO40X2 with numerical aperture 0.95,
whereas, images in Azacytidine inhibitor experiment were taken with UPLSAPO60XO with
numerical aperture 1.35. Images were analysed using the software Imaris (Bitplane) and Ima-
geJ[32].
Inhibition by Azacytidine and Decitabine
For the inhibition assay 5-Aza-2’-cytidine (Sigma) was used in two different concentrations of
10μM and 3 μM whereas 5-Aza-2’deoxycytidine/Decitabine (Sigma) was used in three differ-
ent concentrations of 1.5μM, 1 μM and 0.5 μM. Both Azacytidine and Decitabine were added
to the 0.2x WGP bacterized media. The culture media was changed daily, and the cells were
treated for four consecutive days until the cells reached 20 vegetative cycles, making them be
able to go through autogamy.
Survival test and IES retention PCR
After cells had finished autogamy, 30 post-autogamous cells were transferred into medium
bacterized with K.pneumoniae for the survival test. Cells were monitored for three days
(approximately 12 divisions) and categorized into three groups according to the observed phe-
notype. In parallel, 100ml culture was harvested for DNA extraction using GeneElute–Mam-
malian Genomic DNA Miniprep Kit (Sigma-Aldrich). PCRs were done on different genomic
regions flanking an IES with GoTaq polymerase (Promega). Agarose gel images were taken on
Alpha Innotech MultiImage II AlphaImager HP.
5-methylcytosine in Paramecium
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Genomic DNA extraction
Cells were harvested and washed twice with 10mM Tris-HCl pH 7.4. The cell pellet was then
incubated with the lysis buffer. Cells were incubated with 20μl of RNase A (from GeneElute–
Mammalian Genomic DNA Miniprep Kit Sigma-Aldrich) for five minutes at room tempera-
ture. Afterwards, cells were incubated in three volumes of the lysis buffer (0.5M EDTA, 1%
SDS, 1% N-lauryl sarcosine, 1 mg/ml of proteinase K) at 55˚C for overnight. The cells were
then incubated for 1Hr with an equal volume of Phenol: Chloroform: IAA on a shaker with
gentle shaking. After incubation, the cells were centrifuged at the maximum speed of the table
top centrifuge for 10minutes. The supernatant was then transferred to a clean tube, and geno-
mic DNA was precipitated using 800μl of isopropanol.
The T47D human cell line was purchased from Sigma (catalogue number: 85102201) and
the MCF7 human cell lines were purchased from ATCC (catalogue number: HTB-22D). DNA
was prepared using a Zymo Research Kit (catalogue number: D4068).
Global quantification of 5-methylcytosine using DNA mass spectrometry
Measurements of 5-methylcytosine levels were performed by Zymo Research (http://www.
zymoresearch.com) using mass spectrometry. An SRM-based mass spectrometry assay was
used to quantify 5-hydroxymethyl-2’-deoxycytidine (5HmdC) and 5-methyl-2’-deoxycytidine
(5mdC). The assay was designed to measure 5HmdC concentrations and 5mdC concentra-
tions as a percentage of 2’-deoxyguanosine (dG) (e.g.–[5HmdC]/[dG] and [5mdC]/[dG]). The
calibrated ranges for the analytes were 0–2.5% for 5HmdC and 0–25% for 5mdC using a fixed
40 pmol amount of dG as an internal standard.
Positive controls together with Dev1 genomic DNA samples were sent to Storm Therapeu-
tics Limited where they were enzymatically digested to individual nucleosides according to a
previously optimised protocol[33]. The samples were analysed in both full-scan- and PRM-
mode in an Orbitrap QExactive-HF High-Resolution Mass Spectrometer (Thermo Fisher,
Waltham, Massachusetts, USA). Standard curves were also run indicating a lower limit of
detection of 300pg/ml for each nucleoside.
Bisulfite sequencing analysis
For bisulfite sequencing, total genomic DNA extracted from different time points were sent to
the Lausanne Genomic Technologies Facility at the University of Lausanne. Library prepara-
tion with bisulfite conversion was performed with the Ovation Ultralow Methyl-Seq kit
(Nugen) after spiking in Phi-X lambda DNA to ~0.5% total mass. Paired-end sequencing was
performed on Illumina HiSeq 2500. Sequencing reads in the form of fastq files were processed
following the suggested protocol on Bismark website using version 0.18.1 (https://rawgit.com/
FelixKrueger/Bismark/master/Docs/Bismark_User_Guide.html). First, reads were quality
trimmed and filtered using Trim Galore[34], [35]. Filtered reads were then mapped to the Par-
amecium macronuclear genome (ptetraurelia_mac_51.fa) with options–n 1 and–X 1000.
Methylation calls were then extracted for all C’s with bismark_methylation_extractor com-
mand. Bismark Cytosine reports were combined, processed and analyzed in R.
Human methylation dataset (SRR34552)[36] was used as a positive control for the analysis
workflow. Reads were mapped to human GRC37.
Bisulfite PCR
We used the EpiTect Fast Bisulfite Kit (59802, Qiagen) to do bisulfite conversion on total
gDNA. Primer pair optimized for Bisulfite converted DNA was designed flanking the loci
5-methylcytosine in Paramecium
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predicted to have 5-methylcytosine. Primer pair 5’-ATG GTA TTT AGA TAA TTA TAT
GGG-3’/ 5’-TAT AAA CGA ACA AAT TAA ATA AAC C-3’ was used for PCR ampli-
fication. PCR product was then purified using Wizard SV Gel and PCR Clean-Up System
(Promega) and samples were sent for Sanger sequencing at Microsynth.
Results
Colorimetric and immunofluorescence assays suggest the presence of
cytosine methylation during autogamy
There are no known cytosine methyltransferases encoded in the Paramecium genome to investi-
gate for a functional role during autogamy. This is also the case for other ciliates whose genomes
have been sequenced, including Oxytricha trifallax, where cytosine methylation was recently
reported[30]. To detect the presence of 5mC in Paramecium, we used the EpiSeeker methylated
DNA Quantification Kit (Abcam). Genomic DNA was extracted from vegetative cells, from vege-
tative but starved cells and from cells at various developmental stages. Cytosine methylation was
detected as soon as the cells sensed starvation (either vegetative or those induced to go through
autogamy) and continued to be present at low levels during the early stages of autogamy. The lev-
els were highest in the later stages when the new macronuclei are visible in the cells (Fig 1A).
Immunostaining was performed with an antibody against 5mC on cells harvested and fixed
during vegetative growth and during autogamy. 5-methylcytosine immunofluorescence was
not observed during any stages of the vegetative life cycle; neither in the macronucleus nor in
the micronucleus (Fig 1B). However, as soon as the cells were starved, 5mC signal appeared in
the macronucleus. The signal appears to be dependent on starvation since it is also present in
young cells that are not mature enough to go through autogamy. During autogamy, we
observed 5mC antibody signal in the parental macronucleus as early as the beginning of meio-
sis, and the signal remained present as long as the parental macronuclear fragments were pres-
ent in the DAPI-stained cells (Fig 1C). Moreover, antibody signal was also observed in the
developing macronucleus as soon as the Dev1 stage and was present until Dev3 stages (Fig
1C). As a control, we performed immunostaining with only secondary antibody and we did
not detect any signal in the nucleus (S1A Fig). We also used C.elegans embryo that do not con-
tain 5mC and human embryonic kidney cells (HEK 2939) reported to have the methylation as
controls for our immunofluorescence studies (S1B & S1C Fig, respectively). These results pro-
vide indirect evidence for 5mC incorporation during macronuclear development.
Treatment with Azacytidine and Decitabine affects cell growth
Given the positive 5mC signals during autogamy, we wanted to see if its deposition is necessary for
DNA elimination. Azacytidine and Decitabine (deoxycytidine) are well known nucleosidic and
deoxynucleosidic analogs of cytidine, respectively. Neither of these drugs can be methylated as they
contain a nitrogen at position 5 of the pyrimidine ring. They can also be easily incorporated into
DNA during replication. Additionally, these drugs form a covalent bond with DNA methyltransfer-
ase leading to the degradation of these enzymes, and thus can cause general inhibition of methylation
processes[37], [38]. To look for a possible role of cytosine methylation, we did a chemical treatment
of cells with both Azacytidine and Decitabine. The effective concentration of both the drugs is
known[39–41], 3μM for Azacytidine and 1μM for Decitabine. A Paramecium cell undergoes four
vegetative divisions per day under normal conditions. First, we tested if drug treatment had any aff-
fect on vegetative cells. Cells were treated with either Azacytidine (3μM or 10μM) or Decitabine
(0.4μM, 1μM or 1.5μM) for five consecutive days. We did not observe any morphological or growth
defect during the treatment, and the cells underwent their normal rate of four divisions per day.
5-methylcytosine in Paramecium
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Drug treatment lead to a decrease in 5mC detection via immunofluorescence (S2A Fig,
middle panel). However, we did not observe significant reduction in 5mC signal after decita-
bine treatment using immunofluorescence (S2A Fig, right panel). After the treatment, the cells
were induced to go through autogamy. Furthermore, 30 individual cells were isolated to test if
they could go through the vegetative cell cycle after autogamy. With 3 μM Azacytidine treat-
ment, about 25% cells could not survive after autogamy, whereas, about 35% of cells did not
make the typical four divisions per day (S2B Fig). In the case of Decitabine treatment, only a
mild growth defect was observed, and none of the treatments were lethal (S2D Fig).
To test whether the treatment of Azacytidine or Decitabine affects DNA elimination during
sexual cycle, we used primers flanking the IES regions and performed PCR to check for IES
retention. We could not observe any IES retention after the treatment either of the drugs, sug-
gesting that the treatment with a nucleosidic analog does not affect DNA elimination in the
developing macronucleus (S2C & S2E Fig full length gels in supp. S3 and S4 Figs).
DNA mass-spectrometry analysis to detect DNA 5-methyl cytosine
methylation
Since immunostaining and a commercial kit suggested the presence of methyl cytosines, we
wanted to assess the total percentage of methyl cytosine in the genome. For this, we sent total
genomic DNA isolated from cells starved during vegetative divisions (vegetative starved) and
cells regularly fed vegetatively dividing cell cultures (vegetative unstarved), from a cell culture
containing cells where 40% of the population had fragmented parental macronucleus during
autogamy for DNA mass spectrometry (Zymo Research). We also sent total genomic DNA iso-
lated from a cell culture where most of the cells had visible new macronucleus during autog-
amy and a post-autogamous culture for DNA mass spectrometry.
An SRM-based mass spectrometry assay was used to quantify 5-hydroxymethyl-2’-deoxycy-
tidine (5HmdC) and 5-methyl-2’-deoxycytidine (5mdC). The assay was designed to measure
5HmdC concentrations and 5mdC concentrations as a percentage of 2’-deoxyguanosine (dG)
(e.g.–[5HmdC]/[dG] and [5mdC]/[dG]). Methyl cytosines were only detected in the postauto-
gamous culture and to only about 0.3% genome-wide. Thus, the mass spectrometry results do
not corroborate the immunostaining or colorimetric measurements (Fig 2A). As controls, we
also performed DNA mass spectrometry on genomic DNA isolated from Drosophila, E. coli,
human breast adenocarcinoma MCF-7 and T47F cell lines. Methyl cytosine levels from con-
trols matched previously reported values[42–44] (S5 Fig).
Bisulfite sequencing analysis suggests DNA cytosine methylation is rare or
non-existent
We performed bisulfite converted paired-end sequencing on the samples described above and
spiked-in a small amount of lambda DNA as an internal negative control. Sequencing reads
Fig 1. Detection of 5-methylcytosine by the antibody-based method. (a) Colorimetric assay for total 5-methylCytosine; total gDNA of different
developmental stages was extracted and the assay was carried in biological triplicates, error bar represents the standard deviation, (b)
Immunocytochemistry with antibody against 5-methylcytosine during vegetative growth; veg represents wild type vegetative cells, vegetative Division
represents a cell going through cytokinesis during vegetative division, Vegetative starved is the stage where wild type cells were allowed to make four
divisions and then was starved for 24hrs to block further vegetative divisions, (c) Schematic representation of autogamy in Paramecium; red represents
micronuclei and the developing new macronucleus, blue represents macronucleus, (d) Immunocytochemistry with antibody against 5-methylcytosine
during vegetative growth; Meiosis represents beginning of micronuclear meiosis, Skein represents beginning of the fragmentation of parental
macronucleus, Fragmentation represents a population where about 40% of cells have fragmented parental macronucleus, Dev1 is the stage during
autogamy when most of the cells have visible new macronucleus, Dev 2 is the stage during autogamy when majority of cells have fully developed new
macronucleus ready for karyonidal division, dev 3 is after post karyonidal divison. Orange arrows represent micronucleus, dotted circles show new
macronucleus. Scale bar: 5μm.
https://doi.org/10.1371/journal.pone.0206667.g001
5-methylcytosine in Paramecium
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Fig 2. 5-methylcytosine detection using mass spectrometry and bisulfite sequencing. (a) DNA mass spectrometry analysis showing the percentage of cytosine
methylation, vegetative unstarved; wild type cells were allowed to undergo vegetative divisions, starved vegetative; wild type vegetative cells grown four divisions and
then starved for 24hours before extracting gDNA, 40% fragmented; a population where about 40% of cells have fragmented parental macronucleus during autogamy,
post-autogamous; cells after seven days post autogamy. (b) Bisulfite sequencing analysis on different developmental stages; veg represents wild type vegetative cells,
Veg starved is the stage where wild type cells were allowed to make four divisions and then was starved for 24hrs to block further vegetative divisions mac dev
represents 40% fragmented, (c) Lambda DNA was spiked in sequencing samples as a negative control. (d) raw data from a published human bisulfite dataset was
5-methylcytosine in Paramecium
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were processed using the Bismark workflow[45] and mapped to the Paramecium macronu-
clear genome and lambda genome. As a positive control of the sequencing workflow, we
downloaded the raw data from a published human bisulfite dataset[36] and analyzed it in
parallel.
The paucity of filtered and quality trimmed reads, as well as the high mapping rate to the
macronuclear genome (>60%), attest to the quality of the sequencing dataset. Bisulfite
sequencing relies on the conversion of cytosines to uracil residues but 5-methyl cytosines do
not get converted to uracils. Across all mapped sequenced bases, < 1% of C’s were not con-
verted to T’s (and thus potentially methylated) in all conditions for each of the three sequence
contexts (CG, CHH, CHG–Fig 2B). However, nearly identical results were obtained from the
internal negative control lambda genome (Fig 2C). In contrast, ~75% of Cs in CpG context
were called as C from the control human HSC dataset, consistent with the published findings
[36] (Fig 2D). These results validate the sequencing workflow and suggest that if there is cyto-
sine methylation in Paramecium macronuclear genome, it is a rare event.
For each cytosine in the Paramecium macronuclear genome, we plotted the percent not
converted to thymine. For these analyses, we removed sites in the genome with less than 10X
coverage in all three conditions. The results for each of the three conditions are nearly identical
(S6 Fig, left panel): ~80% of sites had zero not converted C’s, ~19% had less than 10% not con-
verted C’s and less than 1% had greater than 10% not converted C’s. There were 340 sites
(0.002%) with greater than 30% converted C’s in vegetatively grown cells and none in either
starved cells or cells undergoing macronuclear development. There was no bias in C conver-
sion among the three different nucleotide contexts (S6 Fig, right panel)
Furthermore, we tested specific loci using the Epitect Fast DNA Bisulfite Kit (Qiagen) fol-
lowed by Sanger sequencing. For all tested loci, cytosines were converted to thymines, suggest-
ing that they are not methylated (Fig 2E). Therefore, we conclude that if there is DNA
5-methylcytosine in the Paramecium macronuclear genome its abundance is below the limit of
detection of the current techniques available, and unlikely to have a major role.
Discussion
DNA methylation is important for differentiation and development in plants and animals[1],
[46], [47]. Though there was no clear evidence of presence or absence of cytosine methylation
in Paramecium, recent studies identified its presence in Stylonychia lemnae[48] and O. trifallax
[30]. In both the cases, cytosine methylation was shown to take an active part in macronuclear
development, albeit, using different modes. In Stylonychia, it was suggested that demethylation
of two specific promoters correlates with the activation of genes required for macronuclear dif-
ferentiation[49]. On the other hand, Oxytricha uses de novo cytosine methylation for DNA
elimination during conjugation[30]. Apart from these examples, two more ciliates have been
reported to possess cytosine methylation in their genomes[50], [51]. However, in none of the
cases, has the cognate DNA methyltransferase been identified. The current knowledge of the
presence of methylated cytosines and their potential role in macronuclear development
encouraged us to investigate the possible presence of cytosine methylation in P. tetraurelia as
well.
Although our preliminary data using the antibody-based methods (Fig 1) seemed encourag-
ing and suggested the presence of 5mC in Paramecium, these results were contradicted by
downloaded and ran through the workflow. (e) snapshot of mapping of putative loci for methylated cytosine (marked with orange bar) with the reference genome.
Genomic DNA was treated with Epitect Fast DNA Bisulfite Kit (Qiagen) for Bisulfite conversion, PCR product was then sent for Sanger sequencing and mapped with
Geneious software version R8.
https://doi.org/10.1371/journal.pone.0206667.g002
5-methylcytosine in Paramecium
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DNA mass spectrometry and bisulfite sequencing analyses (Fig 2A and 2B–2D). It’s thus likely
that the antibody-based methods have some spurious background signal, such as detection of
methylated RNA or of other unidentified molecules unrelated to 5mC. We were not able to
detect any signals using a different anti-5mC antibody (S1D Fig). Therefore, quantification of
5mC by immunofluorescence and methylated DNA immunopurification (MeDIP), which rely
on the use of antibodies, may give false positives, especially if actual 5mC levels are low.
Together with other techniques, the detection of cytosine methylation in Oxytricha [30] is also
based on these two methods. Therefore, it is essential to take a critical look at the data to infer
the rate of false positives to attain the accurate picture of methylation levels within the genome.
On the other hand, even though bisulfite conversion and sequencing are the gold standard in
detecting 5mC, this method can also give false positives through incomplete conversion. Thus,
including an internal negative standard, such as lambda DNA, is essential to identify the sensi-
tivity of each experiment.
DNA mass spectrometry is considered to be a highly sensitive method to detect DNA
methylation, and indeed showed the presence of cytosine methylation at very low levels in the
postautogamous culture (Fig 2A). Here, we cannot rule out the possibility of bacterial contami-
nation even though the cells were fed with DCM- E. coli strain that does not undergo DNA
methylation. The rate of bacterial contamination in the postautogamous cultures may be
higher owing to a longer incubation period. DNA mass spectrometry or high-performance
chromatography methods are based on the detection of methylation on digested mononucleo-
tides. Thus, we cannot exclude the possibility that the signal detected by these analyses might
come from the residual food in the culture, especially when the detected levels are quite low
[48], [50].
In light of our 5mC results, the effect on cell growth due to the treatment with Azacytidine
or Decitabine (S2 Fig) cannot be attributed to hypomethylation or demethylation, at least
completely. It is known that these analogues can alter gene expression indirectly and not nec-
essarily always by promoter hypomethylation[52]. Furthermore, the drugs could have other
cytotoxic effects in Paramecium. The IESs tested with PCR did not show detectable 5mC, sug-
gesting that macronuclear development may not be affected per se.
In summary, our current study suggests that if 5mC is present in the Paramecium genome
its levels are below the current limits of detection (< 1%). Moreover, even if 5mC is present at
low levels, its unlikely to have a role directing IES excision.
Supporting information
S1 Fig. Effect of inhibitor treatment on cell survival and IES retention. Immunofluores-
cence using; (a) only Alexa Fluor 488 secondary antibody on a population of Paramecium
where majority of cells have fragmented parental macronucleus,(b, left panel) C.elegans
embryo stained against 5- mCytosine as a negative control for immunofluorescence, (c, right
panel) Human embryonic Kidney cells stained against 5-mCytosine (Abcam, ab73938) as a
positive control for immunofluorescence, (d) immunofluorescence against 5-mCytosine
(Diagenode, C15200081) during early and late stages of macronuclear development. Scale bar:
5μm for a, b and c, 7μm for d.
(PDF)
S2 Fig. Effect of inhibitor treatment on cell survival and IES retention. a) Immunocyto-
chemistry with antibody against 5-methylcytosine after Azacytidine and Decitabine treatment
for three consecutive days. Scale bar: 5μm. (b) & (d) Survival test on cells treated with Azacyti-
dine/ Decitabine; sick; cells did not undergo normal vegetative division rate, dead; non-viable
progenies after refeeding, normal; sexual progenies that underwent normal division rate after
5-methylcytosine in Paramecium
PLOS ONE | https://doi.org/10.1371/journal.pone.0206667 October 31, 2018 10 / 14
refeeding. (c) & (e) IES retention PCRs on different loci (full-length gels are presented in S3 &
S4 Figs respectively) with the primers flanking an IES region (S1 Table).
(PDF)
S3 Fig. Full length gels on IES retention PCRs corresponding to S2C Fig.
(PDF)
S4 Fig. Full length gels on IES retention PCRs corresponding to S2E Fig.
(PDF)
S5 Fig. Percentage of methylation calculated after mass spectrometry done on total geno-
mic DNA samples from different Paramecium during autogamy when new macronuclei
are observed in the cell. Drosophila, E. coli, Human MCF7 DNA and Human T47D DNA
(provided by Storm Therapeutics Limited) were used as a positive control for the detection of
methylated cytosines.
(PDF)
S6 Fig. Absence of evidence of C methylation in Paramecium mac genome. Left panel, per-
cent calculated using C/(C + T) for each C in Paramecium genome. There was no bias in C
conversion among the three different nucleotide contexts (right panel).
(PDF)
S1 Table. List of primers. List of primers to check IES retention PCRs.
(PDF)
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